Table 1 Patient characteristics according to the histopathological type of the cervical cancer and type of pelvic exenteration
From: Analysis of long-term outcomes in 44 patients following pelvic exenteration due to cervical cancer
|  | Type of the pelvic exenteration | FIGO stages | Previous hysterectomy | Reoperation within 30 days | Tumor cells on specimen margins | Lymph node metastases | Utero-vaginal or intestino-vaginal fistula | Severe morbidity (n) | ||
|---|---|---|---|---|---|---|---|---|---|---|
Anterior | Total | Posterior | ||||||||
Squamous cell cervical cancer (n = 17) | 3 | 12 | 2 | IB – 3; IIA – 0; IIB – 5, IIIA – 0, IIIB – 5, IVA – 3, IVB - 1 | 2 | 1 | 1 | 1 | 4 | Intestinal fistula (1), reoperation (1), pelvic abscess (2) |
Cervical adenocarcinoma (n = 14) | 3 | 9 | 2 | IB – 1; IIA – 0; IIB – 4, IIIA – 1 IIIB – 3, IVA – 5, IVB - 0 | 1 | 4 | 4 | 5 | 0 | Reoperation (4), intestinal anastomotic leakage (1), Bricker neobladder leakage (1), abdominal wall abscess (1) |
Undifferentiated cervical cancer (n = 1) | 0 | 1 | 0 | IIIB - 1 | 0 | 1 | 0 | 0 | 0 | Intestinal anastomotic leakage (1), reoperation (1) |
Total (n = 32) | 6 | 22 | 4 | Â | 3 | 6 | 5 | 6 | 4 | 13 |
Pelvic exenteration due to cervical cancer recurrence | ||||||||||
Squamous cell cervical cancer (n = 4) | 3 | 1 | 0 | IIB – 1, IVA – 3, | 0 | 0 | 0 | 1 | 3 | Intestinal fistula (1), abdominal wall abscess (2) |
Cervical adenocarcinoma (n = 8) | 6 | 1 | 1 | IIB – 2, IIIB – 2, IVA – 3, IVB - 1 | 0 | 0 | 2 | 3 | 2 | Reoperation (1), abdominal wall abscess (1) |
Total (n = 50) | 9 | 2 | 1 | Â | 0 | 0 | 2 | 4 | 5 | 5 |